(Q71646046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

J. Carlsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

L. Gedda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

C. Grönvik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

T. Hartman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

A. Lindström

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

P. Lindström

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

H. Lundqvist

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

A. Lövqvist

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

J. Malmqvist

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

P. Olsson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521866

15 May 2024

language of work or name

English

0 references

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

30 August 1994

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7521866

full work available at URL

15 May 2024

https://api.elsevier.com/content/article/PII:0360301694905258?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

https://api.elsevier.com/content/article/PII:0360301694905258?httpAccept=text/plain

15 May 2024

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

International Journal of Radiation Oncology Biology Physics

15 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

105-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

Boron neutron capture therapy: linkage of a boronated macromolecule to monoclonal antibodies directed against tumor-associated antigens

20 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Genetic characterization of human KB cell lines resistant to epidermal growth factor: Pseudomonas exotoxin conjugates.

15 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells

15 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Binding of epidermal growth factor-dextran conjugates to cultured glioma cells

15 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy

15 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Intracellular boron localization and uptake in cell cultures using imaging secondary ion mass spectrometry (ion microscopy) for neutron capture therapy for cancer

15 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects

15 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Effect of dextran and dextran modifications on the thermal and proteolytic stability of conjugated bovine testis β-galactosidase and human serum albumin

15 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Strategy for planned radiotherapy of malignant gliomas: Postoperative treatment with combinations of high dose proton irradiation and tumor seeking radionuclides

15 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

The solution structures of epidermal growth factor and transforming growth factor alpha

15 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Influence of Chloroquine and Lidocaine on Retention and Cytotoxic Effects of [131I]EGF: Studies on Cultured Glioma Cells

15 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Effects of 131I-EGF on cultured human glioma cells

15 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.

15 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Present Status of Boron Neutron Capture Therapy

15 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Receptors for epidermal growth factor and other polypeptide mitogens

15 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts

15 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic

15 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Energy Deposition in Small Ellipsoidal Volumes by High-LET Particles: Application to Thermal Neutron Dosimetry

15 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Radiation sensitization by estramustine studies on cultured human prostatic cancer cells

15 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

15 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids

15 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

15 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Preparation and properties of a soluble trypsin-dextran conjugate

15 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy.

15 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells

15 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Possible alteration of the blood-brain barrier by boron-neutron capture therapy

15 May 2024

42

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Preparation of tumor-specific boron compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets

15 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Structural basis for epidermal growth factor receptor function

15 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Human monoclonal antibodies and engineered antibodies in the management of cancer

15 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Distribution of i.v. administered epidermal growth factor in the rat

15 May 2024

46

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Growth factor receptors and the progression of breast cancer

15 May 2024

50

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats

15 May 2024

51

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Analytical calculation of boron- 10 dosage in cell nucleus for neutron capture therapy.

15 May 2024

52

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Neutron capture therapy in support of other radiation treatment

15 May 2024

54

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Expression of epidermal growth factor receptors in human brain tumors

15 May 2024

55

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

15 May 2024

56

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin

15 May 2024

57

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells

15 May 2024

59

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells

15 May 2024

60

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Biodistribution of radioactive epidermal growth factor in normal and tumor bearing mice

15 May 2024

63

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Covalent linkage of carboxypeptidase G2 to soluble dextrans--I. Properties of conjugates and effects on plasma persistence in mice

15 May 2024

64

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Growth factor receptors as targets for antitumor therapy with monoclonal antibodies

15 May 2024

65

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells

15 May 2024

69

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor

15 May 2024

70

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids

15 May 2024

73

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

The type 1 (EGFR-related) family of growth factor receptors and their ligands

15 May 2024

74

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin

15 May 2024

79

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

EGF-ricin A conjugates: Kinetic profiles of cytotoxic effects and resistant cell variants

15 May 2024

80

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit

15 May 2024

83

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds

15 May 2024

85

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Recycling of epidermal growth factor-receptor complexes in A431 cells: identification of dual pathways

15 May 2024

86

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Cell and environment interactions in tumor microregions: the multicell spheroid model

15 May 2024

88

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Epidermal growth factor: the receptor and its function

15 May 2024

89

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas

15 May 2024

90

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Novel carboranyl amino acids and peptides: reagents for antibody modification and subsequent neutron-capture studies.

15 May 2024

91

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice

15 May 2024

92

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Limitations to the killing of tumours using radiolabelled antibodies

15 May 2024

93

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor

15 May 2024

94

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells

15 May 2024

97

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

Strategies for systemic radiotherapy of micrometastases using antibody-targeted 131I.

15 May 2024

98

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

The use of dextran in the treatment of blood loss and shock

15 May 2024

99

1 reference

https://api.crossref.org/works/10.1016/0360-3016(94)90525-8

15 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521866%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference